Suchergebnisse - (Person:"Adhikari, Nilanjan")

PubPharm (119)

11

Glycyrrhizin as a promising kryptonite against SARS-CoV-2 : Clinical, experimental, and theoretical evidences

enthalten in: Journal of molecular structure | 2023

von Banerjee, S. | Baidya, S. | Adhikari, N. | +2

12

Hydrazides as Potential HDAC Inhibitors : Structure-activity Relationships and Biological Implications

enthalten in: Current topics in medicinal chemistry | 2023

von Banerjee, S. | Baidya, S. | Adhikari, N. | +2

13

Selective Inhibitors of Medium-Size S1' Pocket Matrix Metalloproteinases : A Stepping Stone of Future Drug Discovery

enthalten in: Journal of medicinal chemistry | 2022

von Baidya, S. | Banerjee, S. | Adhikari, N. | +1

14

Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer

enthalten in: European journal of medicinal chemistry | 2022

von Pulya, S. | Patel, T. | Paul, M. | +6

15

Ligand-based quantitative structural assessments of SARS-CoV-2 3CLpro inhibitors : An analysis in light of structure-based multi-molecular modeling evidences

enthalten in: Journal of molecular structure | 2022

von Adhikari, N. | Banerjee, S. | Baidya, S. | +2

16

Synthesis, anticancer activity, SAR and binding mode of interaction studies of substituted pentanoic acids : part II

enthalten in: Future medicinal chemistry | 2022

von Datta, S. | Halder, A. | Adhikari, N. | +3

17

Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model

enthalten in: Bioorganic chemistry | 2021

von Routholla, G. | Pulya, S. | Patel, T. | +7

18

Ligand-based design of anticancer MMP2 inhibitors : a review

enthalten in: Future medicinal chemistry | 2021

von Sanyal, S. | Amin, S. | Adhikari, N. | +1

19

Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors

enthalten in: Bioorganic chemistry | 2021

von Routholla, G. | Pulya, S. | Patel, T. | +5

20

Dissecting Histone Deacetylase 3 in Multiple Disease Conditions : Selective Inhibition as a Promising Therapeutic Strategy

enthalten in: Journal of medicinal chemistry | 2021

von Adhikari, N. | Jha, T. | Ghosh, B.